Evidence map›Paper›PMID 35628889›Full record

ArticleJournal of clinical medicine2022

Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome in Women: Effects of Lifestyle Modifications.

Maria Teresa Guagnano, Damiano D'Ardes, Rossi Ilaria, Francesca Santilli, Cosima Schiavone, Marco Bucci, Francesco Cipollone

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Maria Teresa Guagnano"Clinica Medica" Institute, Department of Medicine and Aging Science, "G. D'Annunzio" University of Chieti-Pescara, Vestini Road, 66100 Chieti, Italy.ORCID 0000-0001-7225-0891
Damiano D'Ardes"Clinica Medica" Institute, Department of Medicine and Aging Science, "G. D'Annunzio" University of Chieti-Pescara, Vestini Road, 66100 Chieti, Italy.ORCID 0000-0001-5573-4536
Rossi Ilaria"Clinica Medica" Institute, Department of Medicine and Aging Science, "G. D'Annunzio" University of Chieti-Pescara, Vestini Road, 66100 Chieti, Italy.ORCID 0000-0001-5163-9929
Francesca Santilli"Clinica Medica" Institute, Department of Medicine and Aging Science, "G. D'Annunzio" University of Chieti-Pescara, Vestini Road, 66100 Chieti, Italy.
Cosima SchiavoneUnit of Ultrasound, Department of Medicine and Aging Science, "G. D'Annunzio" University of Chieti-Pescara, Vestini Road, 66100 Chieti, Italy.
Marco Bucci"Clinica Medica" Institute, Department of Medicine and Aging Science, "G. D'Annunzio" University of Chieti-Pescara, Vestini Road, 66100 Chieti, Italy.ORCID 0000-0002-5213-7768
Francesco Cipollone"Clinica Medica" Institute, Department of Medicine and Aging Science, "G. D'Annunzio" University of Chieti-Pescara, Vestini Road, 66100 Chieti, Italy.
University of Chieti-Pescara · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-alcoholic fatty liver disease (NAFLD) is the most widespread liver disease, characterized by fatty acids liver accumulation and subsequent fibrosis. NAFLD prevalence ranges from 80% to 90% in obese subjects and is estimated to be around 50% in patients with metabolic syndrome. In this clinical scenario, diet and lifestyle modifications can play an important role. There are several imaging techniques that can accurately diagnose fatty liver. Recently, ultrasound has acquired a leading role in the diagnosis and follow-up of fatty liver disease. Furthermore, elastosonography represents a valid alternative to liver biopsy. Shear wave elastosonography evaluates the elastic and mechanical properties of liver tissue. The aim is to evaluate the effects of lifestyle and nutritional interventions and a loss of body weight during hepatic steatosis through ultrasonographic and elastosonographic techniques. Thirty-two female subjects with metabolic syndrome were subjected to clinical, anthropometric, and laboratory assessments, as well as abdominal ultrasonographic/elastosonographic measurements taken from enrollment time (T0) and after 3 months (T1) of lifestyle modifications. After 3 months of lifestyle changes, significant weight loss was observed, with a marked improvement in all adiposity indices. The laboratory parameters at T1 showed significant decreases in total and LDL cholesterol, triglycerides, basal blood glucose, 120 min glycaemia, basal insulin and HOMA Index (p < 0.001). A similar improvement was observed at T1 for steatosis degree (p < 0.01) and elastosonographic measurements (Kpa p < 0.001). The linear regression analysis of the baseline conditions documented that the size of the liver positively correlated with body weight, BMI, neck and waist circumferences, waist to height ratio (WhtR), insulin and HOMA Index, fat mass and visceral fat, and steatosis grade. After 3 months, the liver size showed improvement with positive correlations to all previous variables. Hepatic stiffness (Kpa) positively correlated with neck circumference, visceral fat, and ALT, with basal insulin, gamma-GT, and AST, and with waist circumference, WhtR, and fat mass. The degree of steatosis was positively correlated with more variables and with greater statistical significance at T1 with respect to T0. Particularly, the positive correlations between the degree of steatosis and neck circumference (p < 0.001), HOMA Index, and triglycerides (p < 0.001) appeared to be very significant. NAFLD management in women with metabolic syndrome should be focused on lifestyle modifications. Moreover, liver involvement and improvement at follow-up could be evaluated in a non-invasive manner through ultrasonographic and elastosonographic techniques.

Indexed as

dietelastosonographylifestyle modificationsmetabolic syndromeNAFLDobesityultrasound

Identifiers

PMID35628889
PMCPMC9146022
OpenAlexW4280654116

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.